The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global microcarrier market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Microcarriers are beads manufactured using different materials like gelatin, dextran, cellulose, plastic, and glass. They provide anchorage or an attachment surface for the suspended cell culture, which aids in increasing the viability of cells. They also enhance the production capacity, improve culture robustness, facilitate process scale-up, and reduce cell manufacturing costs. As a result, they are widely utilized in cell-line production and with bioreactors. Moreover, as they are easy to handle and have a high surface-to-volume ratio, they are gaining traction worldwide as an alternative to monolayer procedures for nerve and muscle cultures.
Microcarriers are extensively used during the production of vaccines to increase protein-producing and virus-generating adherent cell populations. This, along with the urgent need for mass vaccination to control the spread of the coronavirus disease (COVID-19), represents one of the key factors impelling the market growth. In addition, the rising prevalence of viral diseases is catalyzing the demand for microcarrier-based vaccine delivery systems. These systems modulate the immune responses and other immunostimulatory compounds, thereby increasing the availability of antigens to the immune cells. Apart from this, dissolvable microcarriers composed of cross-linked polysaccharide polymers are widely being used in large-scale cell production and in cell therapy applications. This, in confluence with the rising geriatric population and the risk of developing cancer with age, is catalyzing the demand for cell therapeutics and microcarriers. Furthermore, researchers are focusing on introducing microcarriers using a genetic algorithm and a transient liquid molding optofluidic approach. They are also developing three-dimensional (3D) shaped hydrogel cell microcarriers that allow adherent culture and self-alignment for imaging flow cytometry. This is projected to contribute to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global microcarrier market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, material type, application and end user.
Breakup by Product:
Breakup by Material Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being CESCO Bioengineering Co. Ltd., ChemoMetec A/S, Corning Incorporated, Cytiva (Danaher Corporation), Eppendorf AG, Esco VacciXcell, HiMedia Laboratories, Lonza Group AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc. and VWR International LLC (Avantor Inc.).
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Material Type, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||CESCO Bioengineering Co. Ltd., ChemoMetec A/S, Corning Incorporated, Cytiva (Danaher Corporation), Eppendorf AG, Esco VacciXcell, HiMedia Laboratories, Lonza Group AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc. and VWR International LLC (Avantor Inc.).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at